Monday, September 14, 2026

Cevidoplenib: The Game-Changing Autoimmune Drug Set for Global Launch in 2026

Oscotec's Cevidoplenib, an autoimmune drug, is set for global development with Agios, promising significant growth and revenue potential.

Kim Jong Un Chairs 3-Day Meeting — But Keeps Outcomes Secret

North Korea held a three-day Workers' Party meeting, discussing political, economic, and defense reports, but details were scarce.

North Korea Still Off-Limits for U.S. Travelers Until 2025

The U.S. has renewed its travel ban to North Korea for another year due to risks of arbitrary arrest and detention of Americans.

Geun Uk Kim

No posts to display

Top News

- Our Sponsors Ad -

Follow us